HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-APR-16 5J95 TITLE MAP4K4 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 2-313; COMPND 5 SYNONYM: HPK/GCK-LIKE KINASE HGK,MAPK/ERK KINASE KINASE KINASE 4, COMPND 6 MEKKK 4,NCK-INTERACTING KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP4K4, HGK, KIAA0687, NIK; SOURCE 6 EXPRESSION_SYSTEM: INSECT CELL EXPRESSION VECTOR PTIE1; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 266783 KEYWDS KINASE, INHIBITOR COMPLEX, STRUCTURAL BASED DRUG DESIGN, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LIU REVDAT 2 06-MAR-24 5J95 1 REMARK REVDAT 1 19-APR-17 5J95 0 JRNL AUTH S.LIU JRNL TITL MAP4K4 IN COMPLEX WITH INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 25265 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1288 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.60 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.55 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2731 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2491 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2596 REMARK 3 BIN R VALUE (WORKING SET) : 0.2468 REMARK 3 BIN FREE R VALUE : 0.2938 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.94 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4706 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 8 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 75.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 77.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.27820 REMARK 3 B22 (A**2) : 6.38860 REMARK 3 B33 (A**2) : -12.66670 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.415 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.450 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.273 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.469 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.279 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4871 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6610 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1714 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 121 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 727 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4871 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 621 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5282 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.16 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.94 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.79 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -32.8891 -0.2512 11.7166 REMARK 3 T TENSOR REMARK 3 T11: -0.1069 T22: -0.1658 REMARK 3 T33: -0.0730 T12: 0.0001 REMARK 3 T13: -0.1096 T23: -0.0033 REMARK 3 L TENSOR REMARK 3 L11: 0.6054 L22: 4.0466 REMARK 3 L33: 1.6862 L12: 0.3936 REMARK 3 L13: -0.2570 L23: -1.6829 REMARK 3 S TENSOR REMARK 3 S11: 0.0775 S12: -0.0508 S13: -0.1674 REMARK 3 S21: 0.1620 S22: -0.0936 S23: -0.2945 REMARK 3 S31: 0.2264 S32: 0.0518 S33: 0.0161 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -61.2181 13.7527 22.2843 REMARK 3 T TENSOR REMARK 3 T11: -0.0663 T22: -0.1326 REMARK 3 T33: -0.1113 T12: -0.0569 REMARK 3 T13: 0.0503 T23: 0.0929 REMARK 3 L TENSOR REMARK 3 L11: 2.8829 L22: 1.4356 REMARK 3 L33: 2.3479 L12: -0.3623 REMARK 3 L13: 1.3276 L23: -0.1077 REMARK 3 S TENSOR REMARK 3 S11: 0.1188 S12: -0.4414 S13: -0.3994 REMARK 3 S21: 0.3767 S22: 0.0874 S23: 0.1634 REMARK 3 S31: 0.3098 S32: -0.4213 S33: -0.2062 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5J95 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000220171. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25413 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 96.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 1.13700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH=6.5, 0.2 M NACL, 18% REMARK 280 PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.09000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.20500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.13000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.20500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.09000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.13000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 2 REMARK 465 ASN A 3 REMARK 465 ASP A 4 REMARK 465 SER A 5 REMARK 465 PRO A 6 REMARK 465 ALA A 7 REMARK 465 LYS A 8 REMARK 465 SER A 9 REMARK 465 LEU A 10 REMARK 465 VAL A 11 REMARK 465 ASP A 12 REMARK 465 ILE A 13 REMARK 465 VAL A 174 REMARK 465 SER A 175 REMARK 465 ALA A 176 REMARK 465 GLN A 177 REMARK 465 LEU A 178 REMARK 465 ASP A 179 REMARK 465 ARG A 180 REMARK 465 THR A 181 REMARK 465 VAL A 182 REMARK 465 GLY A 183 REMARK 465 ARG A 184 REMARK 465 ARG A 185 REMARK 465 ARG A 310 REMARK 465 LYS A 311 REMARK 465 LYS A 312 REMARK 465 ARG A 313 REMARK 465 ALA B 2 REMARK 465 ASN B 3 REMARK 465 ASP B 4 REMARK 465 SER B 5 REMARK 465 PRO B 6 REMARK 465 ALA B 7 REMARK 465 LYS B 8 REMARK 465 SER B 9 REMARK 465 ARG B 310 REMARK 465 LYS B 311 REMARK 465 LYS B 312 REMARK 465 ARG B 313 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER B 93 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 22 -78.81 -22.40 REMARK 500 VAL A 28 -68.33 -95.18 REMARK 500 ASN A 33 -88.16 -178.45 REMARK 500 HIS A 78 56.53 -92.03 REMARK 500 HIS A 97 171.91 53.22 REMARK 500 CYS A 108 76.81 -101.28 REMARK 500 ARG A 152 -8.19 79.94 REMARK 500 ASP A 153 53.38 -144.62 REMARK 500 ASP A 171 60.75 61.23 REMARK 500 ASN A 205 68.89 -114.36 REMARK 500 ASP A 207 77.27 -114.27 REMARK 500 ALA A 208 107.71 -52.67 REMARK 500 LEU A 270 40.04 -96.30 REMARK 500 VAL B 28 -61.26 -103.22 REMARK 500 VAL B 31 -84.73 -100.82 REMARK 500 TYR B 36 32.07 -144.63 REMARK 500 GLN B 38 81.82 76.04 REMARK 500 LYS B 46 -67.33 -164.29 REMARK 500 THR B 47 98.24 -178.15 REMARK 500 PRO B 95 94.38 -69.82 REMARK 500 LYS B 121 -89.55 11.97 REMARK 500 ARG B 152 -8.54 75.14 REMARK 500 ASP B 153 54.77 -145.54 REMARK 500 GLU B 204 20.07 105.87 REMARK 500 ASN B 205 63.31 -166.47 REMARK 500 ASP B 207 76.40 -114.03 REMARK 500 ALA B 208 108.37 -53.65 REMARK 500 LEU B 233 12.81 87.55 REMARK 500 LEU B 270 42.73 -96.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6HH A 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ZP5 RELATED DB: PDB REMARK 900 MAP4K4 IN COMPLEX WITH INHIBITOR DBREF 5J95 A 2 313 UNP O95819 M4K4_HUMAN 2 313 DBREF 5J95 B 2 313 UNP O95819 M4K4_HUMAN 2 313 SEQRES 1 A 312 ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP ILE ASP SEQRES 2 A 312 LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE GLU LEU SEQRES 3 A 312 VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN VAL TYR SEQRES 4 A 312 LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA ALA ILE SEQRES 5 A 312 LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU GLU ILE SEQRES 6 A 312 LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER HIS HIS SEQRES 7 A 312 ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE LYS LYS SEQRES 8 A 312 SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU VAL MET SEQRES 9 A 312 GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU VAL LYS SEQRES 10 A 312 ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP ILE ALA SEQRES 11 A 312 TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA HIS LEU SEQRES 12 A 312 HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS GLY GLN SEQRES 13 A 312 ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS LEU VAL SEQRES 14 A 312 ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR VAL GLY SEQRES 15 A 312 ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP MET ALA SEQRES 16 A 312 PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP ALA THR SEQRES 17 A 312 TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY ILE THR SEQRES 18 A 312 ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU CYS ASP SEQRES 19 A 312 MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO ARG ASN SEQRES 20 A 312 PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER LYS LYS SEQRES 21 A 312 PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS ASN TYR SEQRES 22 A 312 MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS HIS PRO SEQRES 23 A 312 PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL ARG ILE SEQRES 24 A 312 GLN LEU LYS ASP HIS ILE ASP ARG THR ARG LYS LYS ARG SEQRES 1 B 312 ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP ILE ASP SEQRES 2 B 312 LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE GLU LEU SEQRES 3 B 312 VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN VAL TYR SEQRES 4 B 312 LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA ALA ILE SEQRES 5 B 312 LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU GLU ILE SEQRES 6 B 312 LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER HIS HIS SEQRES 7 B 312 ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE LYS LYS SEQRES 8 B 312 SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU VAL MET SEQRES 9 B 312 GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU VAL LYS SEQRES 10 B 312 ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP ILE ALA SEQRES 11 B 312 TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA HIS LEU SEQRES 12 B 312 HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS GLY GLN SEQRES 13 B 312 ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS LEU VAL SEQRES 14 B 312 ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR VAL GLY SEQRES 15 B 312 ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP MET ALA SEQRES 16 B 312 PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP ALA THR SEQRES 17 B 312 TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY ILE THR SEQRES 18 B 312 ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU CYS ASP SEQRES 19 B 312 MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO ARG ASN SEQRES 20 B 312 PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER LYS LYS SEQRES 21 B 312 PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS ASN TYR SEQRES 22 B 312 MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS HIS PRO SEQRES 23 B 312 PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL ARG ILE SEQRES 24 B 312 GLN LEU LYS ASP HIS ILE ASP ARG THR ARG LYS LYS ARG HET 6HH A4000 28 HETNAM 6HH 1-{4-[6-AMINO-5-(4-CHLOROPHENYL)PYRIDIN-3- HETNAM 2 6HH YL]PHENYL}CYCLOPENTANE-1-CARBOXYLIC ACID FORMUL 3 6HH C23 H21 CL N2 O2 FORMUL 4 HOH *8(H2 O) HELIX 1 AA1 ASP A 14 LEU A 18 5 5 HELIX 2 AA2 THR A 59 ASP A 61 5 3 HELIX 3 AA3 GLU A 62 SER A 77 1 16 HELIX 4 AA4 SER A 112 ASN A 119 1 8 HELIX 5 AA5 THR A 120 THR A 124 5 5 HELIX 6 AA6 LYS A 126 HIS A 147 1 22 HELIX 7 AA7 LYS A 155 GLN A 157 5 3 HELIX 8 AA8 ALA A 196 ILE A 200 5 5 HELIX 9 AA9 ARG A 213 GLY A 229 1 17 HELIX 10 AB1 HIS A 237 ILE A 245 1 9 HELIX 11 AB2 SER A 259 LEU A 270 1 12 HELIX 12 AB3 ASN A 273 ARG A 277 5 5 HELIX 13 AB4 SER A 279 LYS A 285 1 7 HELIX 14 AB5 HIS A 286 ASP A 291 1 6 HELIX 15 AB6 ASN A 294 ARG A 308 1 15 HELIX 16 AB7 THR B 59 MET B 72 1 14 HELIX 17 AB8 SER B 112 ASN B 119 1 8 HELIX 18 AB9 LYS B 126 HIS B 147 1 22 HELIX 19 AC1 LYS B 155 GLN B 157 5 3 HELIX 20 AC2 GLY B 183 PHE B 188 5 6 HELIX 21 AC3 ALA B 196 ILE B 200 5 5 HELIX 22 AC4 ARG B 213 GLY B 229 1 17 HELIX 23 AC5 HIS B 237 ILE B 245 1 9 HELIX 24 AC6 SER B 259 LEU B 270 1 12 HELIX 25 AC7 ASN B 273 ARG B 277 5 5 HELIX 26 AC8 SER B 279 LYS B 285 1 7 HELIX 27 AC9 HIS B 286 ASP B 291 1 6 HELIX 28 AD1 ASN B 294 ARG B 308 1 15 SHEET 1 AA1 5 PHE A 25 VAL A 30 0 SHEET 2 AA1 5 VAL A 39 HIS A 44 -1 O LYS A 41 N GLU A 29 SHEET 3 AA1 5 LEU A 50 VAL A 58 -1 O ALA A 51 N GLY A 42 SHEET 4 AA1 5 ASP A 99 GLU A 106 -1 O ASP A 99 N VAL A 58 SHEET 5 AA1 5 TYR A 85 LYS A 91 -1 N GLY A 87 O VAL A 104 SHEET 1 AA2 2 VAL A 159 LEU A 161 0 SHEET 2 AA2 2 VAL A 167 LEU A 169 -1 O LYS A 168 N LEU A 160 SHEET 1 AA3 5 PHE B 25 LEU B 27 0 SHEET 2 AA3 5 TYR B 36 HIS B 44 -1 O ARG B 43 N GLU B 26 SHEET 3 AA3 5 LEU B 50 VAL B 58 -1 O ILE B 53 N TYR B 40 SHEET 4 AA3 5 ASP B 99 GLU B 106 -1 O LEU B 101 N MET B 56 SHEET 5 AA3 5 TYR B 85 LYS B 91 -1 N GLY B 87 O VAL B 104 SHEET 1 AA4 2 VAL B 159 LEU B 161 0 SHEET 2 AA4 2 VAL B 167 LEU B 169 -1 O LYS B 168 N LEU B 160 CISPEP 1 HIS A 97 ASP A 98 0 4.01 CISPEP 2 GLY B 37 GLN B 38 0 1.94 CISPEP 3 THR B 47 GLY B 48 0 3.68 CISPEP 4 SER B 93 PRO B 94 0 -3.26 CISPEP 5 GLY B 122 ASN B 123 0 -4.43 SITE 1 AC1 12 VAL A 31 GLY A 32 TYR A 36 VAL A 39 SITE 2 AC1 12 ALA A 52 MET A 105 GLU A 106 CYS A 108 SITE 3 AC1 12 ASP A 115 LEU A 160 VAL A 170 ASP A 171 CRYST1 80.180 92.260 96.410 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012472 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010839 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010372 0.00000